GLMD icon

Galmed Pharmaceuticals
GLMD

Overview Fund Activity

24 hedge funds and large institutions have $7.05M invested in Galmed Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 7 closing their positions.

Holders
24
Holders Change
-2
Holders Change %
-7.69%
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
4
Reduced
5
Closed
7
Calls
$51K
Puts
$429K
Net Calls
-$378K
Net Calls Change
+$46K

Top Buyers

1
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$244K
2
Millennium Management
2
Millennium Management
New York
$97K
3
VF
3
Virtu Financial
New York
$65K
4
LC
4
Lindbrook Capital
California
$21K
5
Group One Trading
5
Group One Trading
Illinois
$13K

Top Sellers

1
II
1
Ibex Investors
Colorado
$1.59M
2
NCM
2
Nantahala Capital Management
Connecticut
$542K
3
Rockefeller Capital Management
3
Rockefeller Capital Management
New York
$0
4
Citadel Advisors
4
Citadel Advisors
Florida
$0
5
Squarepoint
5
Squarepoint
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Citadel Advisors
26
Citadel Advisors
Florida
– – -28,114 Closed
Squarepoint
27
Squarepoint
New York
– – -25,404 Closed
TI
28
Tidal Investments
Wisconsin
– – -24,657 Closed
TRCT
29
Tower Research Capital (TRC)
New York
– – -1,815 Closed
Royal Bank of Canada
30
Royal Bank of Canada
Ontario, Canada
– – -1,000 Closed
SPIA
31
Steward Partners Investment Advisory
New York
– – -500 Closed
CFGS
32
Concourse Financial Group Securities
Alabama
– – – –
1
2